• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

290
28
25
19
19

COUNTRY

13
12
6
3
2

CATEGORIES

  • 200
  • 173
  • 84
  • 40
  • 28
  • 22
  • 16
  • 14
  • 13
  • 11
  • 10
  • 8
  • 5
  • 5
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

65
87
117
459

PUBLISHED

2
21
249
459

PRODUCT TYPE

406
53

Search "Global Cancer Drugs market 2009-2013" returned 459 results.

PRODUCT TITLE

Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies

Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies Summary The leading business intelligence...

September 2013
FROM

Molecular Diagnostics in Cancer Testing

Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added The technologies that come under the umbrella of molecular...

November 2013
FROM
Cancer Generics Market Outlook 2017 Cancer Generics Market Outlook 2017 - Product Thumbnail Image

Cancer Generics Market Outlook 2017

The National Cancer Institute has stated that almost half of the population born today will be diagnosed with cancer at some point during their lifetime With global cancer incidence rising to almost...

July 2013
FROM

Cancer Monoclonal Antibodies Market Forecast to 2017

Cancer, one of the leading causes of death worldwide, affected approximately 13 Million people in 2012 and this figure is expected to grow to 17 Million by 2020 The dramatic increase in the size of...

August 2013
FROM
Nasopharyngeal Cancer - Pipeline Review, H1 2013 Nasopharyngeal Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Nasopharyngeal Cancer - Pipeline Review, H1 2013

Global Markets Direct's, 'Nasopharyngeal Cancer - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development...

February 2013
FROM

Global Lung Cancer Therapeutics Market 2015-2019

About Lung Cancer Cancer occurs when, after undergoing cell transformation, normal cells grow and multiply without control. Lung cancer is a common cause of mortality and morbidity in both developed...

November 2014
FROM
Orphan Drugs - Global Strategic Business Report Orphan Drugs - Global Strategic Business Report - Product Thumbnail Image

Orphan Drugs - Global Strategic Business Report

This report analyzes the worldwide markets for Orphan Drugs in US$ Million The report provides separate comprehensive analytics for the US, Europe, Japan, and Rest of World Annual estimates and forecasts...

August 2013
FROM

Pediatric Cancer - Pipeline Review, H2 2013

Pediatric Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Pediatric Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

August 2013
FROM
Pediatric Cancer - Pipeline Review, H1 2013 Pediatric Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Pediatric Cancer - Pipeline Review, H1 2013

Pediatric Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Pediatric Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

February 2013
FROM

European Drug Delivery Technologies - Market Forecasts to 2017

This research report categorizes the European drug delivery market into oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery These markets are...

June 2013
FROM

Nasopharyngeal Cancer - Pipeline Review, H2 2013

Nasopharyngeal Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Nasopharyngeal Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

July 2013
FROM
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2013 Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2013 - Product Thumbnail Image

Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2013

Bile Duct Cancer (Cholangiocarcinoma) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2013', provides an overview of the indication’s...

April 2013
FROM
Breast Cancer Market Report: 2013 Edition Breast Cancer Market Report: 2013 Edition - Product Thumbnail Image

Breast Cancer Market Report: 2013 Edition

Riding on the back of evolving technological environment, the global healthcare and pharmaceutical industry is now surmounting new acmes. The growth of the respective sector is further filliped by the...

June 2013
FROM

Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities

Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities Summary GBI Research, leading business...

July 2012
FROM

Cancer Supportive Care Products Market to 2016 - Market is Expected to Decline after 2014 Due to Generic Erosion and Entry of Biosimilars

Cancer Supportive Care Products Market to 2016 - Market is Expected to Decline after 2014 Due to Generic Erosion and Entry of Biosimilars Summary GBI Research, the leading business intelligence provider,...

April 2011
FROM

Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Global Forecasts To 2017

The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal...

April 2013
FROM

Metastatic Renal Cell Cancer - Pipeline Review, H1 2013

Metastatic Renal Cell Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Metastatic Renal Cell Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

May 2013
FROM
Bladder Cancer Therapeutics - Global Strategic Business Report Bladder Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Bladder Cancer Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Bladder Cancer Therapeutics in US$ Million. The report provides separate comprehensive analytics for US, Japan, Europe, and Rest of World. Annual estimates...

October 2010
FROM
HPV Testing - Global Strategic Business Report HPV Testing - Global Strategic Business Report - Product Thumbnail Image

HPV Testing - Global Strategic Business Report

This report analyzes the worldwide markets for HPV Testing in US$ Thousand The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World Annual estimates and forecasts...

October 2013
FROM

Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017

'Injectable Drug Delivery Market by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics...

April 2013
FROM
Loading Indicator

Our Clients

Ikea Systems B.V. GlaxoSmithKline PLC BT Group PLC. Philips N.V. BSH Home Appliances Ltd Foreign & Commonwealth Office